|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 5/16 | |
| C07K 16/00 | |||
| C07K 16/24 | |||
| C07K 14/545 | |||
| G01N 33/68 | |||
| A61K 39/395 |
| (11) | Number of the document | 3085773 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16164746.6 |
| Date of filing the European patent application | 2009-06-01 | |
| (97) | Date of publication of the European application | 2016-10-26 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-18 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 57586 P | 2008-05-30 | US | |
| 121391 P | 2008-12-10 | US | |
| 178350 P | 2009-05-14 | US |
| (72) |
SIMARD, John, US
|
| (73) |
XBiotech, Inc,
1055 West Hastings Street, Suite 300, Vancouver, British Columbia V6E 2E9,
CA
|
| (54) | USES OF IL-1 ALPHA ANTIBODIES |
| USES OF IL-1 ALPHA ANTIBODIES |